APPLOVIN CORP CLASS A (APP)
Sector: Information Technology
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Information Technology
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for APP
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| APP | Co-Founder and Chief Executive Officer of Montai Therapeutics and a CEO-Partner of Flagship Pioneering Inc.; Independent Director | 62 | ["Marketing & Digital Media","Experienced public company director","Deep expertise in the tech industry","Extensive CEO and public company experience","Strategic and operational mindset","Background in product development, ad tech, and data privacy","Strong financial, accounting and risk management acumen","Leader in corporate governance","Strong track record in international operations, strategic transactions, and talent development","Provides critical oversight while driving innovation and growth"] | ["C","Nominating and Corporate Governance (Chair)","Audit"] | 2026 |
Biography sourced from the proxy statement filing.
During 2025, Margaret Georgiadis received fees paid or earned in cash of $83,889 and stock awards of $299,894, for a total of $383,783. As of December 31, 2025, Ms. Georgiadis held 720 RSUs. Ms. Georgiadis served as a member of the Audit Committee.